Press Release
31
March
2021
31
March
2021
Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.
08
January
2021
18
September
2018
The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.
09
December
2020
08
December
2020
Innovative technology is being installed on mental health wards at Midlands Partnership NHS Foundation Trust (MPFT) as part of a programme to continuously improve patient safety
18
November
2020
17
November
2020
Oxehealth, a global leader in vision-based patient monitoring and management systems, have this week announced the promotion of Sarah Surrall as Chief Technology Officer.